Colon-targeted active agent delivery carrier and uses thereof
US-2024390501-A1 · Nov 28, 2024 · US
US11090388B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11090388-B2 |
| Application number | US-201615775956-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 14, 2016 |
| Priority date | Nov 13, 2015 |
| Publication date | Aug 17, 2021 |
| Grant date | Aug 17, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a dialysis solution having at least one osmotic agent, with the osmotic agent being a polysaccharide modified by 2-sulfoethyl groups.
Opening claim text (preview).
The invention claimed is: 1. A dialysis solution having at least one osmotic agent, characterized in that the osmotic agent is a modified polysaccharide, wherein the modified polysaccharide is a 2-sulfoethyl starch, characterized in that the starch underlying the 2-sulfoethyl starch is a starch that was reduced with NaBH 4 before the sulfoethylation, and wherein the molar mass of the unmodified sulfoethyl starch is between 1,000 and 20,000 g/mol. 2. A dialysis solution in accordance with claim 1 , characterized in that the modified polysaccharide has a degree of substitution between 0.05 and 1.0. 3. A dialysis solution in accordance with claim 1 , characterized in that the dialysis solution does not contain any further osmotic agent in addition to the modified polysaccharide. 4. A dialysis solution in accordance with claim 1 , characterized in that the dialysis solution furthermore has electrolytes and a buffer system. 5. A dialysis solution in accordance with claim 4 , characterized in that the electrolytes are selected from the group consisting of sodium ions, potassium ions, calcium ions, magnesium ions, chloride ions, and combinations thereof. 6. A dialysis solution in accordance with claim 4 , characterized in that the buffer system is a lactate buffer, a hydrogen carbonate buffer, or a combination thereof. 7. A dialysis solution in accordance with claim 4 , characterized in that the electrolytes, where present and independently of one another, are present in the following concentrations in the dialysis solution (figures in mmol/l): Sodium ions 125-150 Potassium ions 0-4.5 Calcium ions 0-2.5 Magnesium ions 0-5 Chloride ions 90-120 Lactate/Lactic acid/(Hydrogen) carbonate/CO 2 30-60. 8. A dialysis solution in accordance with claim 1 , characterized in that the pH of the dialysis solution is between 5.0 and 8.0. 9. A dialysis solution in accordance with claim 1 for use in peritoneal dialysis. 10. A dialysis solution in accordance with claim 1 , characterized in that the modified polysaccharide has a degree of substitution between 0.2 and 0.5. 11. A dialysis solution in accordance with claim 1 , characterized in that the dialysis solution comprises mixtures of the modified polysaccharide and further osmotic agents. 12. A dialysis solution in accordance with claim 1 , characterized in that the dialysis solution comprises mixtures of the modified polysaccharide and (i) carnitine or (ii) taurine. 13. A dialysis solution in accordance with claim 1 , characterized in that the pH of the dialysis solution is between 5.5 and 6.5. 14. A dialysis solution in accordance with claim 1 , characterized in that the pH of the dialysis solution is between 6.5 and 7.5. 15. A method of preparing an osmotic agent of a dialysis solution in accordance with claim 1 comprising modification of a polysaccharide starch by 2-sulfoethyl groups.
Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin · CPC title
Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine · CPC title
Starch or degraded starch, e.g. amylose, amylopectin · CPC title
Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean) · CPC title
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids (hydroxamic acids A61K31/16; peroxy acids A61K31/327) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.